Navigation Links
Cellectar Expands Clinical Management Team
Date:10/3/2007

mpany expects to initiate Phase I clinical trails in mid-2008.

About Cellectar

Cellectar LLC is a radiopharmaceuticals company that designs and develops products to detect, treat and monitor a wide variety of human cancers. Cellectar's novel product candidates combine lipid-like molecules, phospholipid ethers (PLEs), with radioisotopes that destroy malignant cells. Cellectar's products' unique mechanism of action is based on their selective accumulation and retention in malignant tumors and not normal cells. The company's operations are based in Madison, WI. Cellectar has previously raised approximately $9.0 million from angel investors; including Continuum Investment Partners. For further information about Cellectar, visit the company website at http://www.cellectar.com.

About CLR1404

Cellectar's lead product candidate, CLR1404, is a phospholipid ether (PLE) combined with the radiolabel 131Iodine. Preclinical studies have shown that this compound is selectively retained in malignant cells. In pre-clinical studies, CLR1404 was taken up and retained in 100% of the 40+ malignant tumor types tested. Cellectar plans to move the compound into phase I clinical trials in mid-2008.


'/>"/>
SOURCE Cellectar LLC
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. PromegaExpress Expands Easy Access to Products with New Cabinet
2. Genetic Analysis Systems Enter the Clinical Mainstream
3. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
4. Large Geographic Differences in EpiPen Prescriptions in the U.S., From the Journal of Allergy and Clinical Immunology
5. Sygnis Pharma AG announces date for presentation of clinical results
6. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Clinical Data Suggest Decreased Bleeding Risk in People With Severe Hemophilia A While Maintaining Factor VIII Levels Above One Percent
8. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
9. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
10. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
11. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...NG, Pa., Nov. 20 In res...estions why currently available medications design...ored, ECRI Institute, an independent nonprofit org...n Finasteride for Prevention of Prostate Cancer ... New York Times article, " Drugs to Deter Some Ca...
(Date:11/19/2009)...., Nov. 19 BioCryst Phar... the pricing of a public offering of 5,000,000 sha...ing in gross proceeds of $48.75 million. All of t...o an effective shelf registration statement previo...sion. BioCryst has also granted the underwriters ...
(Date:11/19/2009)... 19 Riverain Medical announced tod...g Canadian medical imaging distributor Christie Gr...nGuard Chest Xray CAD. The exclusive agreement wil...ucts to the Canadian market through Christie Group...SoftView Enhanced Chest Imaging increases the clar...
Breaking Medicine Technology:ECRI Institute Releases Roadmap to the Evidence on Finasteride for Prevention of Prostate Cancer: New Hotline Report to Aid Healthcare Decision Makers and Journalists 2ECRI Institute Releases Roadmap to the Evidence on Finasteride for Prevention of Prostate Cancer: New Hotline Report to Aid Healthcare Decision Makers and Journalists 3BioCryst Announces Pricing of Public Offering of Common Stock 2BioCryst Announces Pricing of Public Offering of Common Stock 3Riverain Medical Partners With The Christie Group In Canada To Offer SoftView Enhanced Chest Imaging and OnGuard Chest X-Ray CAD Technologies 2Scientists Test New Way to Get Drugs to Cancer Cells 53062 1Scientists Test New Way to Get Drugs to Cancer Cells 53062 2Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Monday August 3 2009 53060 1Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Monday August 3 2009 53060 2Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Monday August 3 2009 53060 3Holy Family Memorial Health Network Bolsters Patient Care Quality and Safety in Achieving Stage 6 on HIMSS Analytics EMR Adoption Model 28SM 29 Scale 53058 1Holy Family Memorial Health Network Bolsters Patient Care Quality and Safety in Achieving Stage 6 on HIMSS Analytics EMR Adoption Model 28SM 29 Scale 53058 2Holy Family Memorial Health Network Bolsters Patient Care Quality and Safety in Achieving Stage 6 on HIMSS Analytics EMR Adoption Model 28SM 29 Scale 53058 3Holy Family Memorial Health Network Bolsters Patient Care Quality and Safety in Achieving Stage 6 on HIMSS Analytics EMR Adoption Model 28SM 29 Scale 53058 4Holy Family Memorial Health Network Bolsters Patient Care Quality and Safety in Achieving Stage 6 on HIMSS Analytics EMR Adoption Model 28SM 29 Scale 53058 5
...ny Biosciences announced,today that the first pati...,valomaciclovir (EPB-348) for the treatment of her... is a highly potent anti-viral with enhanced,deliv...dose-finding study is an important milestone in,ou...ky, MD, Chief Executive,Officer. "Shingles, especi...
...tates that acidic treatments benefit poultry ...RT, La., Nov. 6 FreshFx Antimicrobial Solution,wh...cessing, was identified,in an October 2007 Watt Po...athogen reduction dilemma." Citing recent studies...eorgia Associate Professor of Poultry Science Scot...
Other Medicine Technology:Epiphany Biosciences Reports Initiation and Enrollment in Valomaciclovir Study for Shingles 2FreshFx Recognized for use in the Scalder as a Solution to the 'Yield/Pathogen Reduction Dilemma' 2
(Date:11/21/2009)...n Dental Group merges their practice with that of ... (PRWEB) November 21, 2009 -- Th.... David Gibson, Dr. Dean Cloutier, Dr. John Placht... growing practice with that of esteemed colleague ...d he wanted to retire from dentistry in order to c...
(Date:11/20/2009)... /PRNewswire-FirstCall/ - NUCRYST Pharmaceuticals ...areholders will be held on Monday, December 21, 20...oval of two special resolutions. The first special...f all or substantially all of the assets of NUCRYS...asset purchase agreement dated November 10, 2009 a...
(Date:11/20/2009)... Following a recall by Unilever The...sale Shedd,s Country Crock ® Side Dishes DELU... ® Side Dishes DELUXE Four Cheese Pasta due t...wing code dates and UPCs are affected: ,, Shed...r Broccoli Rice 21 oz, UPC 027400218316, Best By N...
(Date:11/20/2009)...swire-USNewswire/ -- The American Dental Associati...stration (FDA) to establish appropriate classifica... concern about the safety of whitening products th...rofessional consultation or examination by a denti...hemically based tooth whitening or bleaching agent...
(Date:11/20/2009)...v. 20 Samuel Gladding i...hat it means to be "happy" during the holidays. As...y in family counseling and chair of the Department... says research shows that it is the pressure to be...sion during the holidays. ,, That,s why he,s ch...
Breaking Medicine News(10 mins):Health News:New Haven Dental Group Expands Their Vision 2Health News:NUCRYST Announces Special Meeting of Shareholders 2Health News:NUCRYST Announces Special Meeting of Shareholders 3Health News:Stop & Shop Alerts Customers to Voluntary Recall by Unilever 2Health News:American Dental Association Petitions FDA to Classify, Regulate Tooth-Whitening Products 2Health News:Why Holidays Don't Have To Be 'Happy' 2
...m Mayo Clinic brings more choice in eating heath f...men than go into any weight loss diets that restri... EveryBody is the name of the report that talks of...ng lifestyle changes. However, it doesn’t mean you...
...rican Heart Association, had said that people suff... risk of heart attacks and developing heart diseas...noted by the systolic blood pressure remaining bet... pre-hypertension conditions. Researchers fro...
... alcohol and certain type of cancers, which will p...uence DNA repair pathways. The study examined t...n (a substance that can induce cancer formation, f...cause they have been shown to protect DNA from oxi...
... decrease the risk of liver cancer.Researchers fro... showed self-reported frequency of coffee consumpt...tment for potential confounders, researchers say t... just 0.58 compared with the non-drinkers. Althoug...
...inical phase of trail and make soon be available a... Flu is caused by virus and the present vaccine...u is an extremely contagious condition and makes o...world's population is infected by flu every year. ...
...arch are working on using virtual reality to help ...(PTSD). // In this research, scientists are c...patients suffering from PTSD to go through the sim...sure therapy, through this procedure of reliving t...
Other Medicine News:Health News:New Healthy Weight Program Makes Healthy Eating More Interesting 2Health News:Risk Of Heart Attack Increase From Pre-Hypertension 2Health News:New Flu Vaccine Can Give Lifetime Protection 2
...RI TREK™ Compact Compressor is for active pa...nywhere and everywhere. The compressor is small an... source optionsworldwide AC compatibility (100 to ... patients the freedom to take aerosol treatments a...
...g Quieter Compressed Air., ,Allied Healthcares Ti...uch quieter than other air compressors that you ma.... The PCS 414 features a durable, mar-resistant st...e unit weighs only 26.5 pounds. The PCS 414 has be...
CompAir XLT Compressor Nebulizer System
CompAir Elite Compressor Nebulizer System
Medicine Products: